OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

20.92USD
24 Dec 2014
Price Change (% chg)

$0.76 (+3.77%)
Prev Close
$20.16
Open
$20.18
Day's High
$21.13
Day's Low
$20.18
Volume
23,380
Avg. Vol
49,399
52-wk High
$42.34
52-wk Low
$16.61

OMED.OQ

Chart for OMED.OQ

About

OncoMed Pharmaceuticals, Inc. (OncoMed) is a clinical development-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells (CSCs). It utilizes its technologies to identify, isolate and evaluate CSCs; identify and/or validate multiple potential... (more)

Overall

Beta: --
Market Cap (Mil.): $624.09
Shares Outstanding (Mil.): 29.83
Dividend: --
Yield (%): --

Financials

  OMED.OQ Industry Sector
P/E (TTM): -- 151.53 38.61
EPS (TTM): -1.33 -- --
ROI: -23.05 -0.59 18.27
ROE: -41.26 -1.72 19.14
Search Stocks

FDA lifts partial hold on OncoMed's cancer drug trials

- OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.

28 Aug 2014

UPDATE 1-FDA lifts partial hold on OncoMed's cancer drug trials

Aug 28 - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.

28 Aug 2014

OncoMed says FDA lifts partial hold on cancer drug trials

Aug 28 - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.

28 Aug 2014

Competitors

  Price Change
Amgen, Inc. (AMGN.OQ) $170.17 +1.69
Astellas Pharma Inc (4503.T) ¥1,713 +3.00
AstraZeneca plc (AZN.L) 4,555.50p +39.00
Bayer AG (BAYGn.DE) €115.20 -0.20
Bayer AG (BAYE.F) -- --
Celgene Corporation (CELG.OQ) $109.60 +3.48
Roche Holding Ltd. (ROG.VX) CHF270.40 -18.30
GlaxoSmithKline plc (GSK.L) 1,385.00p 0.00
Johnson & Johnson (JNJ.N) $104.59 +0.31
Eli Lilly and Co (LLY.N) $70.16 +0.42

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks